The Drug Expert

The Drug Expert
Author: Craig W. Stevens
Publisher: Academic Press
Total Pages: 260
Release: 2020-01-08
Genre: Medical
ISBN: 0128005823

The Drug Expert: A Practical Guide to the Impact of Drug Use in Legal Proceedings targets academic and industry pharmacologists, pharmacology graduate students, and professionals and students of affiliated disciplines, such as pharmacy and toxicology. Users will find it to be an invaluable reference for those involved in the field. In addition, pharmacists and others who increasingly serve as expert witnesses and toxicologists will find an array of very useful information. Focuses on important topics for the consulting pharmacologist, including prescription, over-the-counter and illegal drugs and their effects on criminal and civil proceedings Details the “how-to aspects of being an expert witness in pharmacology by presenting real-life cases and effective tips and experiences Includes several appendices, such as a sample letter of engagement and fee schedule, a litigation report, a consulting invoice and valuable resources

Drug Use for Grown-Ups

Drug Use for Grown-Ups
Author: Dr. Carl L. Hart
Publisher: Penguin
Total Pages: 305
Release: 2022-01-11
Genre: Social Science
ISBN: 1101981660

“Hart’s argument that we need to drastically revise our current view of illegal drugs is both powerful and timely . . . when it comes to the legacy of this country’s war on drugs, we should all share his outrage.” —The New York Times Book Review From one of the world's foremost experts on the subject, a powerful argument that the greatest damage from drugs flows from their being illegal, and a hopeful reckoning with the possibility of their use as part of a responsible and happy life Dr. Carl L. Hart, Ziff Professor at Columbia University and former chair of the Department of Psychology, is one of the world's preeminent experts on the effects of so-called recreational drugs on the human mind and body. Dr. Hart is open about the fact that he uses drugs himself, in a happy balance with the rest of his full and productive life as a researcher and professor, husband, father, and friend. In Drug Use for Grown-Ups, he draws on decades of research and his own personal experience to argue definitively that the criminalization and demonization of drug use--not drugs themselves--have been a tremendous scourge on America, not least in reinforcing this country's enduring structural racism. Dr. Hart did not always have this view. He came of age in one of Miami's most troubled neighborhoods at a time when many ills were being laid at the door of crack cocaine. His initial work as a researcher was aimed at proving that drug use caused bad outcomes. But one problem kept cropping up: the evidence from his research did not support his hypothesis. From inside the massively well-funded research arm of the American war on drugs, he saw how the facts did not support the ideology. The truth was dismissed and distorted in order to keep fear and outrage stoked, the funds rolling in, and Black and brown bodies behind bars. Drug Use for Grown-Ups will be controversial, to be sure: the propaganda war, Dr. Hart argues, has been tremendously effective. Imagine if the only subject of any discussion about driving automobiles was fatal car crashes. Drug Use for Grown-Ups offers a radically different vision: when used responsibly, drugs can enrich and enhance our lives. We have a long way to go, but the vital conversation this book will generate is an extraordinarily important step.

The Selection and Use of Essential Medicines

The Selection and Use of Essential Medicines
Author: WHO Expert Committee on the Selection and Use of Essential Medicines
Publisher: WHO
Total Pages: 144
Release: 2004
Genre: Medical
ISBN:

This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains a progress report on the new procedures for updating the Model List and the development of the WHO Essential Medicines Library. It continues with a section on changes made in revising the Model List followed by a review of some sections such as hypertensive medicines and fast track procedures for deleting items. Annexes include the 13th version of the Model List and items on the list sorted according to their 5-level Anatomical Therapeutic Chemical classification codes.

WHO Expert Committee on Drug Dependence

WHO Expert Committee on Drug Dependence
Author: WHO Expert Committee on Drug Dependence
Publisher:
Total Pages: 26
Release: 2001
Genre: Designer drugs
ISBN: 9789241209038

This report presents the recommendations of the World Health Organization Expert Committee responsible for reviewing information on dependence-producing drugs, in order to assess the need for their international control. It contains a general discussion of new guidelines adopted in 2000 for the review of psychoactive substances, and their implications for the scheduling of ephedrine. It provides an evaluation of six substances, four of which were recommended for international control; and discusses eight others, five of which were recommended for review at a future meeting.

WHO Expert Committee on Drug Dependence

WHO Expert Committee on Drug Dependence
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 222
Release: 2024-04-19
Genre: Law
ISBN: 9240092463

The Forty-sixth Meeting of the World Health Organisation (WHO)’s Expert Committee on Drug Dependence (ECDD) was convened from 16 to 19 October 2023 and was coordinated from the WHO headquarters in Geneva. The Forty-sixth WHO ECDD critically reviewed six new psychoactive substances: including two benzodiazepines (bromazolam, flubromazepam), one novel synthetic opioid (butonitazene), two cathinones/stimulants (3-CMC, dipentylone) and one dissociative-type substance (2-fluorodeschloroketamine). A critical review to consider international scheduling measures was undertaken for each substance so that the Expert Committee could consider whether information about these substances may justify the scheduling or a change in scheduling of a substance in the 1961 or 1971 Conventions. In addition, the Forty-sixth ECDD carried out a pre-review of nitrous oxide and carisoprodol to consider whether current information justified a critical review. This report summarizes the findings of the forty-sixth ECDD meeting.

Rare Disease Drug Development

Rare Disease Drug Development
Author: Raymond A. Huml
Publisher: Springer Nature
Total Pages: 418
Release: 2021-11-08
Genre: Medical
ISBN: 3030786056

This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients. A unique reference, the book begins with narratives on the many challenges faced by rare disease patient and their caregivers. Subsequent chapters underscore the critical, multidimensional role of patient advocacy groups and the novel approaches to related clinical trials, investment decisions, and the optimization of rare disease registries. The book addresses various rare disease drug development processes by disciplines such as oncology, hematology, pediatrics, and gene therapy. Chapters then address the operational aspects of drug development, including approval processes, development accelerations, and market access strategies. The book concludes with reflections on the authors' case for real-world data and evidence generation in orphan medicinal drug development. Rare Disease Drug Development is an expertly written text optimized for biopharmaceutical R&D experts, commercial experts, third-party capital providers, patient advocacy groups, patients, and caregivers.

Who Expert Committee on Drug Dependence

Who Expert Committee on Drug Dependence
Author: WHO Expert Committee on Drug Dependence. Meeting
Publisher: World Health Organization
Total Pages: 48
Release: 2016
Genre: Medical
ISBN: 9241209984

The WHO Expert Committee on Drug Dependence (ECDD) is responsible for assessing psychoactive substances for possible control under the international drug control conventions. The ECDD reviews the therapeutic usefulness, the liability for abuse and dependence, and the public health and social harm potential of each substance under review. After the ECDD advises the Director-General of WHO as to whether to schedule or to amend the scheduling status of a substance, the Director-General will, as appropriate, communicate the recommendations to the United Nations Secretary-General. The Secretary-General communicates the advice to the Commission on Narcotic Drugs (CND), as appropriate. This report presents the recommendations of the thirty-seventh meeting of the WHO Expert Committee on Drug Dependence. The report summarizes the review of nine substances and the ECDD's recommendations for the scheduling of seven substances. The report also provides updates on ketamine and cannabis, as requested by resolutions of the Commission on Narcotic Drugs. It contains updates on the work of international bodies concerned with controlled substances, as well as summaries of the follow-up discussions on recommendations made at the previous ECDD meeting, and on the discussions on criteria for assessing new psychoactive substances and on terminology.

Brenner and Stevens’ Pharmacology

Brenner and Stevens’ Pharmacology
Author: Craig W. Stevens
Publisher: Elsevier Health Sciences
Total Pages: 611
Release: 2022-04-06
Genre: Medical
ISBN: 0323758991

More detailed than an outlined review but less overwhelming than an encyclopedic reference, Brenner and Stevens’ Pharmacology, 6th Edition, focuses on the essential principles you need to know in a concise, easy-to-understand manner. Authored by Craig W. Stevens, PhD, this highly illustrated introductory text helps you learn and retain key information in pharmacology—taking you from course exams and the USMLE Step 1 right through to clinical practice. New and extensively revised content keeps you up to date with the latest pharmacologic mechanisms and applications. Teaches the fundamental aspects of pharmacology using full-color illustrations, detailed explanations, and a consistent format to present classification of drugs for each system/disease. Helps you understand both the basic science foundations and clinical applications of pharmacology, with useful tables, drug classifications boxes, case studies, and self-assessments in each chapter to help you review and prepare for course exams and Step 1. Includes the latest drugs and therapeutic indications (more than 100 are new to this edition), along with an entirely new chapter on recent developments of immunopharmacology drugs, including antivirals and vaccinations. Addresses key topics such as antiviral and monoclonal drugs to treat COVID-19, the opioid epidemic, and gene therapy. Features more than 700 new and updated images, with many revised figures focused on clearing presenting the mechanism of action of drugs. Includes access to bonus eBook content such as animations, an additional glossary, chapter-by-chapter summaries and case studies, a full list of featured drugs, 150 USMLE-style self-assessment questions, and more.